ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORT IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER

被引:0
|
作者
KONECNY, G [1 ]
UNTCH, M [1 ]
BAUERFEIND, I [1 ]
PICHE, E [1 ]
NESTLEKRAMLING, C [1 ]
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,FRAUENHEILKUNDE & GEBURTSHILFE KLIN & POLIKLIN,MUNICH,GERMANY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:79 / 79
页数:1
相关论文
共 50 条
  • [1] ACCELERATED CHEMOTHERAPY WITH HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE PLUS R-MET-HUG-CSF IN LOCALLY ADVANCED AND METASTATIC BREAST-CANCER
    SCINTO, AF
    FERRARESI, V
    CAMPIONI, N
    TONACHELLA, R
    PIARULLI, L
    SACCHI, I
    GIANNARELLI, D
    COGNETTI, F
    ANNALS OF ONCOLOGY, 1995, 6 (07) : 665 - 671
  • [2] Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer
    De Rosa, L
    Lalle, M
    Perillo, A
    Pierelli, L
    Salerno, MG
    Cortesi, E
    Martelli, O
    Pandolfi, A
    Amodeo, R
    Marzetti, L
    Mancuso, S
    Scambia, G
    ANTICANCER RESEARCH, 2001, 21 (2B) : 1367 - 1370
  • [3] PHASE-II TRIAL OF HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
    SCINTO, AF
    CERCATO, MC
    BOTTI, C
    TONACHELLA, R
    FERRARESI, V
    DELBIANCO, S
    SACCHI, I
    COGNETTI, F
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1285 - 1288
  • [4] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
    LEVI, JA
    BEITH, JM
    SNYDER, RD
    TATTERSALL, MH
    BELL, D
    WHEELER, H
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (05): : 474 - 478
  • [5] HIGH-DOSE EPIRUBICIN AS A SINGLE AGENT IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER
    FOUNTZILAS, G
    SKARLOS, D
    PAVLIDIS, NA
    MAKRANTONAKIS, P
    TSAVARIS, N
    KALOGERAFOUNTZILA, A
    GIANNAKAKIS, T
    BEER, M
    KOSMIDIS, P
    TUMORI, 1991, 77 (03) : 232 - 236
  • [6] HIGH-DOSE EPIRUBICIN AND R-MET-HU G-CSF (FILGRASTIM) IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
    FOUNTZILAS, G
    SKARLOS, D
    KATSOHIS, C
    PAVLIDIS, N
    GIANNAKAKIS, T
    BAFALOUKOS, D
    FAHANTIDIS, E
    KLOUVAS, G
    BEER, M
    KOSMIDIS, P
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (01): : 23 - 28
  • [7] Treatment of advanced refractory breast cancer with docetaxel alternating with epirubicin and cyclophosphamide (EC)+G-CSF
    Valencak, J
    Kornek, GV
    Haider, K
    Raderer, M
    Kwasny, W
    Bareck, E
    Weinlander, G
    Depisch, D
    Kovats, E
    Scheithauer, W
    ANNALS OF ONCOLOGY, 1998, 9 : 180 - 180
  • [8] Treatment of advanced refractory breast cancer with docetaxel alternating with epirubicin and cyclophosphamide (EC)+G-CSF
    Weinländer, G
    Kornek, GV
    Haider, K
    Raderer, M
    Valencak, J
    Kwasny, W
    Bareck, E
    Depisch, D
    Kovats, E
    Scheithauer, W
    BRITISH JOURNAL OF CANCER, 1998, 78 : 10 - 10
  • [9] Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer
    Honkoop, AH
    vanderWall, E
    Feller, N
    Schuurhuis, GJ
    vanderVijgh, WJF
    Boven, E
    vanGroeningen, CJ
    Giaccone, G
    Hoekman, K
    Vermorken, JB
    Wagstaff, J
    Pinedo, HM
    ANNALS OF ONCOLOGY, 1997, 8 (10) : 957 - 962
  • [10] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    E. Espinosa
    S. Morales
    P. Borrega
    A. Casas
    C. Madroñal
    I. Machengs
    J. A. Illarramendi
    J. Lizón
    J. A. Moreno
    J. Belón
    J. Janáriz
    M. de la Puente
    T. Checa
    J. R. Mel
    M. González Barón
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 546 - 552